Progress in Molecular Biology and Translational Science: Glycans and Glycosaminoglycans as Clinical Biomarkers and Therapeutics – Part B (Volume 163)
Original price was: $185.32.$109.01Current price is: $109.01.
9780128177402, Academic Press, Lijuan, Zhang
Original price was: $185.32.$109.01Current price is: $109.01.
Adobooks Marketplace
Related Products
Author: Zhang, Lijuan
Brand: Academic Press
Edition: 1
ISBN: 9780128177402
Release Date: 10-05-2019
Package Dimensions: 9.3 x 6.3 x 1.3 inches
Languages: English
Binding: Hardcover
Number Of Pages: 551
Details: Glycans and Glycosaminoglycans as Clinical Biomarkers and Therapeutics – Part B, Volume 163 in the Progress in Molecular Biology and Translational Science series, provides informative monographs on a variety of research topics related to Glycans and glycosaminoglycans as clinical biomarkers and therapeutics. Topics in this update include an Overview of Fugal Glycan-based Therapeutics, Heparin: An Essential Drug for Modern Medicine, Low Molecular Weight Heparins and Their Clinical Applications, The Clinical Use of Fondaparinux: A Synthetic Heparin Pentasaccharid, Heparinoids as Clinically Used Drugs, Marine Glycan-Derived Therapeutics in China, Efficacy of Heparinoid PSS in Treating Cardiovascular and other Diseases―30 Years Clinical Applications in China, and more. Includes comprehensive coverage of molecular biology Presents ample use of tables, diagrams, schemata and color figures to enhance the reader’s ability to rapidly grasp the information provided Contains contributions from renowned experts in the field
User Reviews
Be the first to review “Progress in Molecular Biology and Translational Science: Glycans and Glycosaminoglycans as Clinical Biomarkers and Therapeutics – Part B (Volume 163)”
Vendor Information
- Store Name: Adobooks Marketplace
- Vendor: Adobooks Marketplace
- 4.71 rating from 7 reviews
Original price was: $185.32.$109.01Current price is: $109.01.
There are no reviews yet.